PBM

Propel Bio Management Portfolio holdings

AUM $159M
1-Year Est. Return 60.94%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+60.94%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$159M
AUM Growth
+$41.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$6.15M
2
+$5.53M
3
+$5.24M
4
VOR icon
Vor Biopharma
VOR
+$4.44M
5
OBIO icon
Orchestra BioMed
OBIO
+$3.82M

Top Sells

1
+$3.5M
2
+$2.15M
3
+$1.68M
4
IVA
Inventiva
IVA
+$1.68M
5
OCS icon
Oculis Holding
OCS
+$1.34M

Sector Composition

1 Healthcare 80.98%
2 Energy 19.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAGP icon
1
Plains GP Holdings
PAGP
$4.82B
$30.2M 19.02%
1,272,360
ACHV icon
2
Achieve Life Sciences
ACHV
$538M
$11.4M 7.17%
3,786,425
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$765M
$9.35M 5.9%
841,272
+100,354
DCTH icon
4
Delcath Systems
DCTH
$372M
$9.16M 5.77%
979,698
+541,189
CORT icon
5
Corcept Therapeutics
CORT
$7.46B
$6.02M 3.8%
+147,828
ABEO icon
6
Abeona Therapeutics
ABEO
$329M
$6.01M 3.79%
1,329,899
+499,119
VOR icon
7
Vor Biopharma
VOR
$811M
$5.59M 3.52%
+314,543
KYTX icon
8
Kyverna Therapeutics
KYTX
$518M
$5.59M 3.52%
644,421
-22,245
MIST icon
9
Milestone Pharmaceuticals
MIST
$177M
$5.08M 3.2%
4,118,321
CLDX icon
10
Celldex Therapeutics
CLDX
$2.47B
$4.14M 2.61%
131,364
-22,936
CMPS
11
Compass Pathways
CMPS
$1.76B
$4.12M 2.6%
742,049
-119,729
VRDN icon
12
Viridian Therapeutics
VRDN
$1.95B
$4.09M 2.58%
210,163
-72,368
IVA
13
Inventiva
IVA
$1.03B
$3.99M 2.52%
724,678
-275,322
SABS icon
14
SAB Biotherapeutics
SABS
$275M
$3.89M 2.45%
1,012,790
+359,909
OBIO icon
15
Orchestra BioMed
OBIO
$234M
$3.83M 2.41%
+896,701
FDMT icon
16
4D Molecular Therapeutics
FDMT
$518M
$3.58M 2.26%
+380,420
OCS icon
17
Oculis Holding
OCS
$1.37B
$3.28M 2.07%
122,223
-50,616
OCUL icon
18
Ocular Therapeutix
OCUL
$1.97B
$3.23M 2.03%
+382,375
UPB
19
Upstream Bio Inc
UPB
$455M
$3.1M 1.95%
+341,779
AQST icon
20
Aquestive Therapeutics
AQST
$504M
$2.95M 1.86%
+710,988
EYPT icon
21
EyePoint Inc
EYPT
$1.14B
$2.79M 1.76%
+215,825
TRVI icon
22
Trevi Therapeutics
TRVI
$2.01B
$2.65M 1.67%
+223,802
ZVRA icon
23
Zevra Therapeutics
ZVRA
$685M
$2.64M 1.66%
282,418
+218,735
IMUX icon
24
Immunic
IMUX
$204M
$2.62M 1.65%
+234,478
CHRS icon
25
Coherus Oncology
CHRS
$245M
$2.41M 1.52%
+1,420,550
1
2